West Pharmaceutical Services Inc
NYSE:WST

Watchlist Manager
West Pharmaceutical Services Inc Logo
West Pharmaceutical Services Inc
NYSE:WST
Watchlist
Price: 322.55 USD 1%
Market Cap: 23.4B USD
Have any thoughts about
West Pharmaceutical Services Inc?
Write Note

Operating Margin
West Pharmaceutical Services Inc

20.4%
Current
25%
Average
2.4%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
20.4%
=
Operating Profit
585.8m
/
Revenue
2.9B

Operating Margin Across Competitors

Country US
Market Cap 23.4B USD
Operating Margin
20%
Country US
Market Cap 1.3T USD
Operating Margin
14%
Country US
Market Cap 200.7B USD
Operating Margin
17%
Country US
Market Cap 172.1B USD
Operating Margin
21%
Country KR
Market Cap 67.8T KRW
Operating Margin
31%
Country CH
Market Cap 38.6B CHF
Operating Margin
13%
Country US
Market Cap 38.8B USD
Operating Margin
25%
Country US
Market Cap 36.9B USD
Operating Margin
14%
Country US
Market Cap 26.9B USD
Operating Margin
28%
Country US
Market Cap 23.2B USD
Operating Margin
29%
Country US
Market Cap 22.7B USD
Operating Margin
8%
No Stocks Found

West Pharmaceutical Services Inc
Glance View

Market Cap
23.4B USD
Industry
Life Sciences Tools & Services
Economic Moat
Narrow

West Pharmaceutical Services Inc. is a leading global manufacturer of advanced drug delivery systems and medical device components, catering primarily to the pharmaceutical and biotechnology sectors. Founded in 1923, the company has built a robust reputation for its innovative solutions that enhance the safety and efficacy of medications. With a focus on producing high-quality packaging and delivery systems, West’s product lineup includes prefillable syringes, stoppers, and highly specialized devices that contribute to the growing demand for biologics and complex medications. This focus on quality has positioned West as a trusted partner for major pharmaceutical companies, and its strategic global footprint allows it to meet the rising demands of health systems worldwide. As the healthcare landscape evolves, West Pharmaceutical Services stands to benefit from several key industry trends, including the increased emphasis on patient-centric therapies and the demand for reliable and efficient drug administration methods. Investors can find assurance in the company’s commitment to innovation, as it invests heavily in research and development to stay ahead of emerging trends and regulatory changes. Additionally, West’s consistent financial performance, with steady revenue growth and healthy profit margins, showcases its resilience and operational efficiency. As the biopharmaceutical market continues to expand, West’s strategic alignment with cutting-edge therapeutic developments positions it well for future growth, painting a promising picture for potential investors looking to tap into the burgeoning healthcare sector.

WST Intrinsic Value
217.11 USD
Overvaluation 33%
Intrinsic Value
Price

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
20.4%
=
Operating Profit
585.8m
/
Revenue
2.9B
What is the Operating Margin of West Pharmaceutical Services Inc?

Based on West Pharmaceutical Services Inc's most recent financial statements, the company has Operating Margin of 20.4%.